WB | 咨询技术 | Human,Mouse,Rat |
IF | 咨询技术 | Human,Mouse,Rat |
IHC | 1/25-1/100 | Human,Mouse,Rat |
ICC | 技术咨询 | Human,Mouse,Rat |
FCM | 咨询技术 | Human,Mouse,Rat |
Elisa | 1/2000-1/5000 | Human,Mouse,Rat |
Aliases | DEZ; RVER1; ChemR23; CHEMERINR |
Host/Isotype | Rabbit IgG |
Antibody Type | Primary antibody |
Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
Species Reactivity | Human |
Immunogen | Synthetic peptide of human CMKLR1 |
Formulation | Purified antibody in PBS with 0.05% sodium azide and 50% glycerol. |
+ +
以下是关于CMKLR1抗体的3篇参考文献及其摘要概括:
1. **文献名称**: "Chemerin induces mitochondrial dysfunction in adipocytes via CMKLR1-dependent signaling"
**作者**: Li et al., 2019
**摘要**: 该研究通过使用抗CMKLR1抗体进行免疫沉淀和Western blot分析,揭示了Chemerin通过结合CMKLR1受体激活下游信号通路,导致脂肪细胞线粒体功能障碍,从而促进肥胖相关代谢异常。
2. **文献名称**: "CMKLR1 modulates macrophage polarization in sepsis through NF-κB pathway inhibition"
**作者**: Wang et al., 2021
**摘要**: 研究利用CMKLR1特异性中和抗体,在小鼠败血症模型中证明阻断CMKLR1可抑制NF-κB通路,减少促炎性M1型巨噬细胞极化,改善全身性炎症反应和器官损伤。
3. **文献名称**: "Development of a humanized anti-CMKLR1 monoclonal antibody for therapeutic targeting of inflammatory diseases"
**作者**: Smith et al., 2022
**摘要**: 该文献报道了一种人源化抗CMKLR1单克隆抗体的开发,通过体外和体内实验验证其高亲和力及特异性,证明其能有效抑制Chemerin介导的炎症反应,为类风湿性关节炎等疾病提供了潜在治疗策略。
注:以上文献信息为模拟示例,实际文献需通过学术数据库检索确认。
×